Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Pharmacogenetics of anti-cancer drugs].

Annales pharmaceutiques francaises - 1 Nov 2007

Gamelin E, Boisdron-Celle M, Morel A, Capitain O

Abstract excerpt

Toxic side-effects of cytotoxic drugs is a stumbling-block of chemotherapy due to the fact that their therapeutic index is narrow. New approaches are necessary to individualize the treatments. Pharmacogenetic analysis is facilitated by easy access to the patient genome via simple blood samples, b...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Enzymes
Share to Pharmacogenetics
Share to Polymorphism, Single Nucleotide

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antineoplastic Agents

Source

Identifiers

PMID: 18079671
DOI: 10.1016/s0003-4509(07)74198-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18079671-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Pharmacogenetics of anti-cancer drugs].PMID 18079671Read ↗

[Pharmacogenetics of anticancer drugs].Semantic proximity Read ↗

Genetic determinants of cancer drug efficacy and toxicity: practical considerations and perspectives.Semantic proximity Read ↗

[SNPs associated with adverse effects].Semantic proximity Read ↗

Pharmacogenetics of Drugs Used in the Treatment of CancersSemantic proximity Read ↗

Role of Genetic Polymorphisms in Drug-Metabolizing Enzyme-Mediated Toxicity and Pharmacokinetic Resistance to Anti-Cancer Agents: A Review on the Pharmacogenomics Aspect.Semantic proximity Read ↗

[State of the art of pharmacogenetic diagnostics in drug therapy].Semantic proximity Read ↗

[Pharmacogenomics and chemotherapy].Semantic proximity Read ↗

[Pro or con the phenotyping/genotyping of patients treated by 5-Fluorouracil to prevent adverse drug reactions?].Semantic proximity Read ↗

Cancer pharmacogeneticsSemantic proximity Read ↗

Application of pharmacogenetics in oncologySemantic proximity Read ↗

Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx GuidelinesSemantic proximity Read ↗

Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized MedicineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.